📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. (2019)

First Author: Miras AD

Attributed to: RAMP2 and the glucagon receptor: important in the pathogenesis of non-alcoholic fatty liver disease? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2213-8587(19)30157-3

PubMed Identifier: 31174993

Publication URI: http://europepmc.org/abstract/MED/31174993

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Diabetes & endocrinology

Issue: 7

ISSN: 2213-8587